Zura Bio Limited Class A Ordinary Shares (ZURA NASDAQ) stock market data APIs
$1.3001
0(0%)
as of July 14, 2025
Try our APIs with
free plan!
Zura Bio Limited Class A Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Prev. Close
1.3001
Open
1.3001
High
1.3649
Low
1.2693
52 wk Range
0.97-5.07
Market Cap
80 437 K
Shares Outstanding
61 875 K
EPS
-0.19
Beta
-0.129
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zura Bio Limited Class A Ordinary Shares data using free add-ons & libraries
Get Zura Bio Limited Class A Ordinary Shares Fundamental Data
Zura Bio Limited Class A Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -55 180 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: -0.29
Get Zura Bio Limited Class A Ordinary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zura Bio Limited Class A Ordinary Shares News
New
Zura Bio appoints Eric Hyllengren as CFO
Zura Bio (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA]) has announced the appointment [https://seekingalpha.com/pr/20152922-zura-bio-announces-chief-financial-officer-transition] of Eric Hylleng...
Zura Bio names Eric Hyllengren as new CFO, effective July 7
HENDERSON, Nev. - Zura Bio Limited (NASDAQ:ZURA) announced Tuesday that Eric Hyllengren will become its new Chief Financial Officer on July 7, 2025. Hyllengren will replace current CFO Verender Badial...
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
Sagimet Biosciences Inc. SAN MATEO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid ...
3 Undervalued Biotech Stocks With Breakout Potential
Undervalued biotech stocks will always be relevant for the savvy investor. The biotech world is evolving rapidly, with pharmaceutical giants tirelessly building on their pipelines and technologies. W...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
